These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 22821594)

  • 1. Applications and limitations of in silico models in drug discovery.
    Sacan A; Ekins S; Kortagere S
    Methods Mol Biol; 2012; 910():87-124. PubMed ID: 22821594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of computational methods in pharmaceutical sciences.
    Kortagere S; Lill M; Kerrigan J
    Methods Mol Biol; 2012; 929():21-48. PubMed ID: 23007425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoinformatics-applications in food chemistry.
    Martinez-Mayorga K; Medina-Franco JL
    Adv Food Nutr Res; 2009; 58():33-56. PubMed ID: 19878857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico pharmacology for a multidisciplinary drug discovery process.
    Ortega SS; Cara LC; Salvador MK
    Drug Metabol Drug Interact; 2012; 27(4):199-207. PubMed ID: 23152402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of structural biology in drug discovery.
    Tari LW
    Methods Mol Biol; 2012; 841():1-27. PubMed ID: 22222446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collection and preparation of molecular databases for virtual screening.
    Saxena AK; Prathipati P
    SAR QSAR Environ Res; 2006 Aug; 17(4):371-92. PubMed ID: 16920660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining biophysical screening and X-ray crystallography for fragment-based drug discovery.
    Hennig M; Ruf A; Huber W
    Top Curr Chem; 2012; 317():115-43. PubMed ID: 21837555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charting, navigating, and populating natural product chemical space for drug discovery.
    Lachance H; Wetzel S; Kumar K; Waldmann H
    J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining NMR and X-ray crystallography in fragment-based drug discovery: discovery of highly potent and selective BACE-1 inhibitors.
    Wyss DF; Wang YS; Eaton HL; Strickland C; Voigt JH; Zhu Z; Stamford AW
    Top Curr Chem; 2012; 317():83-114. PubMed ID: 21647837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hit finding: towards 'smarter' approaches.
    Langer T; Hoffmann R; Bryant S; Lesur B
    Curr Opin Pharmacol; 2009 Oct; 9(5):589-93. PubMed ID: 19576852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quo vadis, virtual screening? A comprehensive survey of prospective applications.
    Ripphausen P; Nisius B; Peltason L; Bajorath J
    J Med Chem; 2010 Dec; 53(24):8461-7. PubMed ID: 20929257
    [No Abstract]   [Full Text] [Related]  

  • 14. Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with Forecaster, a novel platform for drug discovery.
    Therrien E; Englebienne P; Arrowsmith AG; Mendoza-Sanchez R; Corbeil CR; Weill N; Campagna-Slater V; Moitessier N
    J Chem Inf Model; 2012 Jan; 52(1):210-24. PubMed ID: 22133077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel CDK1 inhibitors by combining pharmacophore modeling, QSAR analysis and in silico screening followed by in vitro bioassay.
    Al-Sha'er MA; Taha MO
    Eur J Med Chem; 2010 Sep; 45(9):4316-30. PubMed ID: 20638755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoinformatics and library design.
    Zhou JZ
    Methods Mol Biol; 2011; 685():27-52. PubMed ID: 20981517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-ray crystallography in drug discovery.
    Carvalho AL; Trincão J; Romão MJ
    Methods Mol Biol; 2009; 572():31-56. PubMed ID: 20694684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using computational techniques in fragment-based drug discovery.
    Desjarlais RL
    Methods Enzymol; 2011; 493():137-55. PubMed ID: 21371590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Established and emerging trends in computational drug discovery in the structural genomics era.
    Taboureau O; Baell JB; Fernández-Recio J; Villoutreix BO
    Chem Biol; 2012 Jan; 19(1):29-41. PubMed ID: 22284352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
    Langer T; Krovat EM
    Curr Opin Drug Discov Devel; 2003 May; 6(3):370-6. PubMed ID: 12833670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.